Close
Nordic 9Nordic 9

Autobio Diagnostics (investor - Corporate Investor)

China autobio.com.cn
See something wrong or missing? Let us know
Offices:Shanghai

Autobio Diagnostics is one of the leading clinical diagnostics companies in China.

Average round investment:11.38M USD
Average number per year:1.0
Distribution: 2018 (1)
Portfolio companies: Finland Mobidiag
Mostly invests in: Finland Finland (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Autobio Diagnostics

Name Criteria
Germany Bosch Ventures
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 1.7
Germany SHS Capital
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 2.0
Switzerland Swisscanto Invest
71%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 2.0
Norway Hadean Ventures
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 2.2
United Kingdom Wellington Partners
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 2.6
United Kingdom ETF Partners
70%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 2.6
Netherlands Inkef Capital
69%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 3.0
United States Biospring Partners
68%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 1.0
United States Adjacent
68%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Average number of deals per year: 1.0
United Kingdom Octopus Ventures
68%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B, SAAS
  • Common investees countries: Finland
  • Average number of deals per year: 3.5
Top